Holen Sie sich die Stockscreener-App
11.62
9.64%
-1.24
Handel nachbörslich:
11.60
-0.02
-0.17%
Schlusskurs vom Vortag:
$12.86
Offen:
$12.7
24-Stunden-Volumen:
7.18M
Relative Volume:
4.36
Marktkapitalisierung:
$1.15B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.84M
KGV:
-24.72
EPS:
-0.47
Netto-Cashflow:
$-44.23M
1W Leistung:
-13.93%
1M Leistung:
-34.54%
6M Leistung:
+13.92%
1J Leistung:
-10.48%
1-Tages-Spanne:
$10.98
$12.70
1-Wochen-Bereich:
$10.98
$14.00
52-Wochen-Spanne:
$10.01
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
Firmenname
Ars Pharmaceuticals Inc
Sektor
Branche
Telefon
858-771-9307
Adresse
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Vergleichen Sie SPRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
11.62 | 1.27B | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-08-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | Bestätigt | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | Raymond James | Outperform |
| 2024-03-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Wedbush | Outperform |
| 2023-01-03 | Eingeleitet | William Blair | Outperform |
| 2022-12-13 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Ars Pharmaceuticals Inc Aktie (SPRY) Neueste Nachrichten
Custom watchlist performance reports with ARS Pharmaceuticals IncJuly 2025 Action & Weekly Setup with High ROI Potential - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.Oil Prices & Community Verified Trade Signals - Newser
What machine learning models say about ARS Pharmaceuticals Inc.Share Buyback & Weekly Watchlist for Consistent Profits - Newser
Published on: 2025-08-30 17:11:44 - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
ARS Pharmaceuticals Faces Wider Loss in Q2, Stirring Market Concerns - StocksToTrade
Real time pattern detection on ARS Pharmaceuticals Inc. stockGlobal Markets & Daily Technical Forecast Reports - Newser
Is ARS Pharmaceuticals Inc. forming a bottoming baseWeekly Market Report & Safe Entry Point Identification - Newser
Using data models to predict ARS Pharmaceuticals Inc. stock movementWeekly Trade Recap & Weekly Hot Stock Watchlists - Newser
Trading Bots Trigger Alerts on ARS Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
ARS Pharmaceuticals Down 9% as Lupin Files Generic Neffy Application - AInvest
Price momentum metrics for ARS Pharmaceuticals Inc. explained2025 Big Picture & Long-Term Capital Growth Ideas - Newser
What machine learning models say about ARS Pharmaceuticals IncJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
ARS Pharmaceuticals Inc. recovery potential after sell offRate Cut & Free Weekly Watchlist of Top Performers - Newser
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsMarket Activity Summary & AI Driven Stock Price Forecasts - Newser
What the charts say about ARS Pharmaceuticals Inc. today2025 Biggest Moves & AI Driven Stock Reports - Newser
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveTrade Ideas & Daily Price Action Insights - Newser
Custom watchlist performance reports with ARS Pharmaceuticals Inc.Weekly Stock Recap & Real-Time Volume Surge Alerts - Newser
How high can ARS Pharmaceuticals Inc. stock go2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to ARS Pharmaceuticals Inc.2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Detecting price anomalies in ARS Pharmaceuticals Inc. with AIJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
ARS Pharmaceuticals Faces Financial Struggles as Q2 Loss Exceeds Estimates - StocksToTrade
ARS Pharmaceuticals Plunges 8.7%—What Legal Storm Could Sink Neffy's Future? - AInvest
What recovery options are there for ARS Pharmaceuticals Inc.2025 Historical Comparison & Stock Market Timing Techniques - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stock2025 Retail Activity & Real-Time Volume Triggers - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsEarnings Miss & Low Risk High Reward Ideas - Newser
Published on: 2025-08-29 02:08:09 - Newser
What indicators show strength in ARS Pharmaceuticals Inc.Recession Risk & Verified Entry Point Detection - Newser
Is ARS Pharmaceuticals Inc. backed by strong institutional buying2025 Top Gainers & Safe Entry Trade Signal Reports - sundaytimes.kr
Real time social sentiment graph for ARS Pharmaceuticals Inc.Market Risk Report & Real-Time Buy Signal Alerts - Newser
Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):